
Michael Thomas Pulley MD PhD
Headache, Neurophysiology
Associate Professor, Neurology, University of Florida College of Medicine
Join to View Full Profile
580 W 8th StUFJP NeurologyJacksonville, FL 32209
Phone+1 904-244-3960
Fax+1 904-244-3425
Dr. Pulley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Pulley is a neurologist based in Jacksonville, FL, with subspecialties in neuromuscular medicine and nerve conduction/EMG. He completed his medical education at the University of Maryland School of Medicine, followed by a residency in neurology at Duke University Hospital, and a fellowship in clinical neurophysiology at Johns Hopkins University. Dr. Pulley has extensive experience in general neurology, neuromuscular medicine, clinical neurophysiology, and muscular dystrophy. His recent publications focus on treatments and trials for neuromuscular conditions like myasthenia gravis and amyotrophic lateral sclerosis, with his work being published in respected journals such as The Lancet Neurology, Muscle and Nerve and Neurology. Additionally, he is involved in several clinical trials related to myasthenia gravis and chronic inflammatory demyelinating polyneuropathy (CIDP).
Education & Training
- Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 1997 - 1998
- Duke University HospitalResidency, Neurology, 1994 - 1997
- Sinai Hospital of BaltimoreInternship, Internal Medicine, 1993 - 1994
- University of Maryland School of MedicineClass of 1993
Certifications & Licensure
- FL State Medical License 1998 - 2027
- GA State Medical License 1998 - 2019
- MD State Medical License 1998 - 1999
- NC State Medical License 1994 - 1999
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
Clinical Trials
- Efficacy of Methotrexate in Myasthenia Gravis Start of enrollment: 2009 Apr 01
- International Guillain-Barré Syndrome Outcome Study Start of enrollment: 2012 May 01
- A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis Start of enrollment: 2015 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsSafety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial.Ali A Habib, Chongbo Zhao, Inmaculada Aban, Marcondes Cavalcante França Jr, Jorge Gustavo José
The Lancet. Neurology. 2025-02-01 - A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.Salman Bhai, Todd Levine, Dan Moore, Robert Bowser, Andrew J Heim
Muscle & Nerve. 2025-01-01 - 2 citationsPrimary lateral sclerosis natural history study - planning, designing, and early enrollment.Hiroshi Mitsumoto, Grace Jang, Ikjae Lee, Zachary Simmons, Alexander V Sherman
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2023-08-01
Press Mentions
- Clinical Effects of the Self-Administered Subcutaneous Complement Inhibitor Zilucoplan in Patients with Moderate to Severe Generalized Myasthenia GravisFebruary 17th, 2020
- 'Us Against ALS': Jacksonville Lawman, Family Make Every Minute Count; CEOs Join in Fundraiser for NonprofitJuly 19th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: